At the news
? NEUTRALIMPACT 2/10 8-K filed Jul 9, 2026 at 21:03 ET
Ionis Pharmaceuticals filed an 8-K reaffirming its previously announced FY2026 financial guidance from April 29, 2026, with no changes. The filing contains no new financial data, preliminary results, or material updates, only a confirmation of prior guidance.
- Ionis reaffirms previously announced FY2026 financial guidance unchanged from April 29, 2026 Q1 earnings release
- No new financial metrics, preliminary results, or guidance revisions disclosed
- Filing contains only a brief Regulation FD disclosure with forward-looking statements
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access